$MRVL

Koopmans Chris sold $2.8M of MRVL (indirect holdings)

Koopmans Chris (President and COO) sold 10,000 indirectly-held shares of Marvell Technology, Inc. (MRVL) at $281.92 ($2.82M total) on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Koopmans Chris
Published Jul 1, 2026, 9:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 9:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MRVL
Neutral
medium confidence
Mentioned
$MRVL
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRVLNeutralLow
01

Why it matters

The disclosure updates the record of insider activity (open-market sale) but does not introduce new company fundamentals or guidance.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 structure limits interpretive value.

03

What to watch

The filing notes indirect holdings and post-transaction share count, but provides no context on total insider exposure, other concurrent sales, or whether the plan size/timing is typical.

Relevance 5/10Novelty 5/10Timing: filed 2026-07-01 (after-hours) for an insider sale executed the same day

Background

This is an SEC Form 4 insider transaction disclosure for Marvell Technology, Inc. (MRVL).

Company-level read

Ticker impact

$MRVLNeutralMedium confidence
Context

Marvell’s President and COO Chris Koopmans sold 10,000 shares in an open-market transaction at $281.92 on 2026-07-01 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any impact is likely brief and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider sale with a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling. The article contains no new operational, financial, or regulatory catalyst.

Market effects

Minimal; this is company-specific insider transaction data with no disclosed sector-wide catalyst.

Minimal; no macro/regional linkage beyond general US equity sentiment.

Minimal; no international deal/regulatory development mentioned.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations, so traders may ignore it for directional bias.

Key entities

  • Marvell Technology, Inc.

    Subject of the Form 4 insider transaction; President and COO sold shares under a 10b5-1 plan.

  • Koopmans Chris

    President and COO; executed an open-market sale of 10,000 shares at $281.92 on 2026-07-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TSMMedAI 8/10

Marvell Technology and Taiwan Semiconductor are No-Brainer Picks: They Have What Wins in a Gold Rush

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, positioning them as key players in AI infrastructure. TSM's Q2 2026 revenue rose 36% YoY to $40.2B, with advanced nodes driving 77% of wafer revenue. MRVL's Q2 2027 revenue increased 36.5% YoY to $2.74B, with data center revenue up 46% YoY. Both companies are seen as essential for AI development, with TSM benefiting from broad industry demand and MRVL tied to hyperscaler custom silicon cycles.

$TSMHighAI 8/10

Marvell Technology and Taiwan Semiconductor are No

Taiwan Semiconductor (TSM) and Marvell (MRVL) reported strong earnings, with TSM posting $40.20B revenue and $4.31 EPS, while MRVL saw 36.5% revenue growth and 46% data center revenue increase. TSM's advanced nodes drove 77% of wafer revenue, and MRVL's custom silicon business is expected to double by fiscal 2028. Both companies are key players in AI infrastructure.

$MRVLMedAI 8/10

Marvell stock is down 36% from recent all-time highs; can it get its mojo back?

Marvell Technology (MRVL) shares have fallen 36% from their all-time high, trading at $213.33 in pre-market. Despite a 226% gain over the past year, the stock dropped 7.9% post-earnings due to margin compression concerns and deferred long-term guidance. The company reported Q2 revenue of $2.74B (+37% YoY) and raised FY2027 guidance to ~$12B. Analysts remain bullish, with targets up to $400, but bears cite margin pressures and potential AI capex slowdowns. Investor Day in October is a key catalys

$MRVLHighAI 8/10

MRVL Stock Heads For Worst Day In A Month After Q2: Analyst Sees Blue-Chip Customers, Broad Portfolio As Healthy Growth Signals

Marvell Technology (MRVL) shares fell 8.2% premarket after Q2 results, despite a new AI chip deal with Google. Analysts highlighted its blue-chip customers and diversified portfolio as growth drivers. Morningstar raised its price target to $300, while Goldman Sachs maintained a 'Neutral' rating with a $195 target. MRVL reported $2.74B in sales, up 37%, and raised fiscal 2028 sales guidance to $18B.